JLP:Jubilee Metals was the biggest loser, dropping 12% on profit taking and losing about £500 value. Now those sells are out of the way I anticipate a steady rise into profitability, unless they shoot themselves in the foot like they usually do.
IKA:Ilika kept going up and up, but is now going down and down. There was a 7% drop this week so they are 16% down now after getting within a whisker of being in the black.
SBTX:SkinBioTherapeutics is suffering as people sell them to buy OPTI:Optibiotix, or at least that's what seems to happen when one of the two companies does well. This will languish until the next deal turns up. It was meant to be "imminent" before Christmas, so hopefully there won't be too much longer to wait.
TRMR:Tremor almost recovered last week's losses and climbed 8% this week. Things are looking fairly good for this going into the black in the next 6 months so I can actually make a trade in my so-called trading account.
Share of the Week is my beloved OPTI:Optibiotix. The 8p climb is 12% and I just need the same again next week to get into profit.
Rather volatile I think.
The trend line is quite steep now, so it's going to take some turning around.
Here's the ISA and share accounts
| Weekly Change | |||
| Cash | £11.99 | +£0 | |
| Portfolio cost | £57,788.78 | +£19.83 | |
| Portfolio sell value (bid price-commission) | £43,459.65 | (-24.8%) | +£3,770.93 |
| Potential profits | £0 | +£0 | |
| Yr 5 Dividends | £0.63 | +£0 | |
| Yr 5 Profit from sales | £-167.28 | +£0 | |
| Yr 5 Average monthly cash profit | -£30.90 | (-0.6%) | +£1.24 |
| Total Dividends | £1,342.93 | +£0 | |
| Total Profit from sales | £20,224.13 | +£0 | |
| Average monthly cash profit | £395.49 | (8.2%) | -£1.70 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Performance/Injection | 12.7% | -0.1% | |
| Compound performance | 57% | +0% |
The cost went up by £19.83 as I foolishly applied for MAIS:Maistro shares in their open offer. The shares are no longer traded on the AIM market, but I figured the risk of flushing £20 down the drain to take my holding to 200,000 shares was worth it, just in case they manage to salvage anything from the mess. I don't hold out much hope, but the most I can possibly lose is the £142 I've put in so far, which isn't going to break the bank.
Aside from that, most of the rise is down to OPTI:Optibiotix, and there's still nothing in profit after IKA:Ilika and JLP:Jubilee Metals decided to go into reverse just before they went green.
Still a long way below the red line, but thank goodness we didn't cross the orange.
Still £15K in the red and it's almost been in the red for a whole year.
Here's the SIPP after week 218
| Weekly Change | ||||
| Cash | £74.75 | +£0 | ||
| Portfolio cost | £46,995.31 | +£0 | ||
| Portfolio sell value (bid price - commission) |
£39,314.62 | (-16.3%) | +£3,490.11 | |
| Potential profits | £167.97 | -£195.00 | ||
| Yr 5 Dividends | £0 | +£0 | ||
| Yr 5 Interest | £0.02 | +£0 | ||
| Yr 5 Profit from sales | £0 | +£0 | ||
| Yr 5 Average monthly cash profit | -£12.38 | (-0.3%) | +£1.38 | |
| Total Dividends | £1,899.24 | +£0 | ||
| Total Interest | £0.18 | +£0 | ||
| Total Profit from sales | £12,549.10 | +£0 | ||
| Average monthly cash profit | £277.82 | (7.1%) | -£1.28 | |
| (Sold stocks profit + Dividends - Fees / Months) | ||||
| Performance/Injection | 11.2% | +0% | ||
| Compound performance | 47% | +0% |
Great increase thanks to OPTI:Optibiotix, but CAML:Central Asia Metals dropped by another 3% and slashed my potential profits by £195. This is now at the level where I feel I should buy some more.
Nearer the red line than the orange - very good.
Only about £8K in the red, but for over 6 months now.
The trading account looks like this after week 184
| Weekly Change | |||
| Cash | £48.24 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,318.66 | (-43.2%) | +£7.54 |
| Potential profits | £0 | +£0 | |
| Year 4 Dividends | £13.20 | +£0 | |
| Year 4 Profit | £0 | +£0 | |
| Yr 4 Average monthly cash profit | £2.04 | (1.1%) | -£0.08 |
| Dividends | £47.92 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£0.39 | (-0.2%) | +£0 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Performance/Injection | -0.2% | +0% | |
| Compound performance | -1% | +0% |
Hardly any change, as the increase in TRMR:Tremor was almost zapped by drops in everything else. Things are going on with TALY:Tally beta testing their app, so hopefully we won't have too long to wait for them to lift the suspension so I can see whether it's going to be possible to get rid of them.
Just bumbling along in a state of desperation.
The right side the the trend line, and it's a shallow one - but trapped rather a long way below the zero line.
Here's the fantasy magic formula account
| Weekly Change | |||
| Cash | £153.61 | +£0 | |
| Portfolio cost | £29,846.39 | +£0 | |
| Portfolio sell value (bid price - commission) | £30,549.54 | (+2.4%) | -£620.08 |
| Potential profits | £1,646.34 | -£252.08 | |
| Year 1 Dividends | £0 | +£0 | |
| Year 1 Profit | £0 | +£0 | |
| Yr 1 Average monthly cash profit | £0 | (0%) | +£0 |
| Dividends | £0 | +£0 | |
| Profit from sales | £0 | +£0 | |
| Average monthly cash profit | £0 | (0%) | +£0 |
| (Sold stocks profit + Dividends - Fees / Months) |
A pretty dreadful week, dropping £620 on value, £252 of which was reduced profits. The house builders are all still doing very well, around 20% up. Lots of shares have tanked though, with KAZ:Kaz Minerals and BUR:Burford Capital both down 14%, BMN:Bushveld Minerals down 12% and DGOC:Diversified Gas & Oil down 11%. Those are all AIM shares or shares I would avoid on environmental grounds, so when I put this into practice for real I should be a bit safer.
That's it - I'm just hoping OPTI:Optibiotix has some momentum behind the share price now, as there's visibility of cash coming in and some gigantic deals ramping up. A Sweetbiotix announcement would light the blue touch paper.
No comments:
Post a Comment